| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |